Neti Prasad V S V, Howell Roger W
Department of Radiology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey 07103, USA.
J Nucl Med. 2004 Jun;45(6):1050-8.
Radiopharmaceuticals are generally distributed nonuniformly in tissue. At the microscopic level, only a fraction of the cells in tissue are labeled. Consequently, the labeled cells receive an absorbed dose from radioactivity within the cell (self-dose) as well as an absorbed dose from radioactivity in surrounding cells (cross-dose). On the other hand, unlabeled cells only receive a cross-dose. This work uses a novel approach to examine the lethal effects of microscopic nonuniformities of (131)I individually on the labeled and unlabeled cells.
A multicellular tissue model was used to investigate the lethality of microscopic nonuniform distributions of (131)I. Mammalian cells (V79) were dyed with CFDA-SE (carboxy fluorescein diacetate succinimidyl ester) and labeled with (131)I-iododeoxyuridine ((131)IdU). The dyed labeled cells were then mixed with equal numbers of unlabeled cells, and 3-dimensional tissue constructs (4 x 10(6) cells) were formed by centrifugation in a small tube. This resulted in a uniform distribution of (131)I at the macroscopic level but nonuniform distribution at the multicellular level, wherein 50% of the cells were labeled. The multicellular clusters were maintained at 10.5 degrees C for 72 h to allow (131)I decays to accumulate. The clusters were then dismantled and the labeled (dyed) and unlabeled (undyed) cells were separately seeded for colony formation using a fluorescence-activated cell sorter.
The unlabeled cells, which received only a cross-dose, exhibited a mean lethal dose D(37) of 4.0 +/- 0.3 Gy. In contrast, the labeled cells received both a self-dose and a cross-dose. Isolating the effects of the self-dose resulted in a D(37) of 1.2 +/- 0.3 Gy, which was about 3.3 times more toxic per unit dose than the cross-dose. The reason for these differences appears to be primarily related to the higher relative biological effectiveness of the self-dose delivered by (131)IdU compared with the cross-dose. Theoretical modeling of the killing of labeled and unlabeled cells was achieved by considering the cellular self-doses and cross-doses.
Cellular self-doses and cross-doses play an important role in determining the biological response of tissue to microscopic nonuniform distributions of (131)I. Prediction of the biological response requires that both self-doses and cross-doses be considered along with their relative lethality per unit dose.
放射性药物在组织中通常分布不均匀。在微观层面,组织中只有一小部分细胞被标记。因此,被标记的细胞会从细胞内的放射性中接受吸收剂量(自身剂量)以及从周围细胞的放射性中接受吸收剂量(交叉剂量)。另一方面,未标记的细胞只接受交叉剂量。这项工作采用了一种新颖的方法来研究¹³¹I微观不均匀性对标记细胞和未标记细胞的致死效应。
使用多细胞组织模型来研究¹³¹I微观不均匀分布的致死性。将哺乳动物细胞(V79)用羧基荧光素二乙酸琥珀酰亚胺酯(CFDA - SE)染色,并用¹³¹I - 碘脱氧尿苷(¹³¹IdU)标记。然后将染色的标记细胞与等量的未标记细胞混合,并通过在小管中离心形成三维组织构建体(4×10⁶个细胞)。这导致¹³¹I在宏观层面上分布均匀,但在多细胞层面上分布不均匀,其中50%的细胞被标记。将多细胞簇在10.5℃下维持72小时,以使¹³¹I衰变积累。然后将簇拆解,使用荧光激活细胞分选仪分别接种标记(染色)和未标记(未染色)的细胞以形成集落。
仅接受交叉剂量的未标记细胞,其平均致死剂量D₃₇为4.0±0.3 Gy。相比之下,标记细胞既接受自身剂量也接受交叉剂量。分离自身剂量的效应得出D₃₇为1.2±0.3 Gy,其每单位剂量的毒性比交叉剂量高约3.3倍。这些差异的原因似乎主要与¹³¹IdU传递的自身剂量相对于交叉剂量具有更高的相对生物有效性有关。通过考虑细胞自身剂量和交叉剂量,实现了对标记和未标记细胞杀伤的理论建模。
细胞自身剂量和交叉剂量在确定组织对¹³¹I微观不均匀分布的生物学反应中起重要作用。预测生物学反应需要同时考虑自身剂量和交叉剂量以及它们每单位剂量的相对致死性。